Cross-tolerance to the hypothermic effect of Δ8-tetrahydrocannabinol 11-hydroxy-Δ8-tetrahydrocannabinol and chlorpromazine in the mouse

Ikuo Yamamoto, Kazuhito Watanabe, Shizuo Narimatsu, Koichi Hamajima, Hidetoshi Yoshimura

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)


When a 5 mg/kg i.v. dose of Δ8-tetrahydrocannabinol (Δ8-THC) and 11-hydroxy-Δ8-tetrahydrocannabinol (11-OH-Δ8-THC) was administered daily to mice, tolerance to their hypothermic effects developed quickly. Cross-tolerance to the hypothermic effect also developed between Δ8-THC and 11-OH-Δ8-THC. Tolerance development was dose-dependent and dose-effect experiments indicated that the magnitude of the tolerance developed to 11-OH-Δ8-THC was greater than that to Δ8-THC. Both cannabinoids were cross-tolerant to chlorpromazine in the hypothermic effect, but not to morphine, pentobarbital and reserpine under the conditions used. The present results suggest that 11-OH-Δ8-THC has some role in the development of tolerance to the hypothermic effect of Δ8-THC in mice.

Original languageEnglish
Pages (from-to)159-166
Number of pages8
JournalEuropean Journal of Pharmacology
Issue number2
Publication statusPublished - May 8 1985


  • 11-Hydroxy-Δ-tetrahydrocannabinol
  • Centrally acting drugs
  • Chlorpromazine
  • Cross-tolerance
  • Hypothermia
  • Δ-Tetrahydrocannabinol

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Cross-tolerance to the hypothermic effect of Δ<sup>8</sup>-tetrahydrocannabinol 11-hydroxy-Δ<sup>8</sup>-tetrahydrocannabinol and chlorpromazine in the mouse'. Together they form a unique fingerprint.

Cite this